• US 20130096197A1
  • Filed: 12/11/2012
  • Published: 04/18/2013
  • Est. Priority Date: 02/10/2009
  • Status: Active Grant
First Claim
Patent Images

1. A method of reducing triglycerides in a subject having a fasting baseline triglyceride level of 500 mg/dl to about 1500 mg/dl comprising, administering orally to the subject 4 capsules per day, each capsule comprising about 900 mg to about 1 g of ethyl eicosapentaenoate and not more than about 3% docosahexaenoic acid or its esters, by weight of total fatty acids present, for a period of 12 weeks to effect a reduction in triglycerides in the subject.

View all claims

    Thank you for your feedback